CRISPR Therapeutics Announces $280 Mln Direct Offering Of Shares At $71.50/Share; Stock Drops

CRISPR Therapeutics AG (CRSP), Tuesday announced the pricing of approximately $280 million direct offering of shares at $71.50 per share, including a premium of more than 10 percent of the company's 30-day volume-weighted average price.

Samarth Kulkarni, chief executive officer and chairman of CRISPR Therapeutics, said, "This financing bolsters our already strong balance sheet, provides the opportunity for additional value creation, and gives us the flexibility to reach sustainability without requiring additional capital."

The financing led by EcoR1 Capital and SR One, is expected to close on or about February 27.

Currently, CRISPR's stock is sliding 3.70 percent, to $73.51 over the previous close of $76.44 on the Nasdaq.

For comments and feedback contact: editorial@rttnews.com

Business News

Looking to Invest in the Best Biotech Stocks? Subscribe to RTT Biotech Investor.
Next Story
Editors Pick
Coca-Cola Q4 Profit Down 3%, But Meets Estimates
Beverages giant Coca-Cola Co. (KO) reported Tuesday a profit for the fourth quarter that declined 3 percent from last year, reflecting steeply lower other income and higher interest expense, despite a 7 percent revenue growth. Adjusted earnings per share met analysts' expectations, while quarterly revenues topped it.
Uber, Lyft, DoorDash Drivers To Strike On Valentine's Day
Drivers of rideshare and delivery network companies Uber Technologies, Inc., Lyft, Inc., and DoorDash, Inc., are calling for a strike on Valentines Day, February 14, citing mistreatment by the app companies over wages and safety. As per two driver groups, drivers will picket in several U.S. cities located near airports demanding changes from Uber, Lyft, DoorDash, and all the app companies...
JetBlue Jumps As Carl Icahn Reports 9.91% Stake
JetBlue Airways Corp.'s shares gained about 16 percent in the extended trading on Monday on Nasdaq after activist investor Carl Icahn reported around 10 percent stake in the airline. In a filing with the U.S. Securities And Exchange Commission, Icahn reported owning 33.62 million shares, representing 9.91 percent stake. JetBlue had around 339.28 million shares of Common Stock outstanding...